Study on H3K9 acetylation modification and TLR9 immune regulation mechanism in patients with anti-HBV treatment using thymosin a1 combined with entecavir
H.-P. v, K. Wang, W. Du, H.-H. Cao, Q.-Y. Zhong, S.-C. Yin, J.-B. Zhong, F.-W. Li
This study investigates how H3K9 acetylation modification affects TLR9 expression and immune response in patients treated with thymosin a1 and entecavir for hepatitis B.
bioRxiv · Oct 31, 2020 · PreprintPharmacology & Toxicology